Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killing.
作者信息
Sedwick W D, Fyfe M J, Hamrell M, Laszlo J
出版信息
Adv Enzyme Regul. 1978;17:399-416. doi: 10.1016/0065-2571(79)90024-4.
PMID:294129
Abstract
摘要
相似文献
1
Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killing.
Adv Enzyme Regul. 1978;17:399-416. doi: 10.1016/0065-2571(79)90024-4.
2
Deoxyuridine incorporation as a useful measure of methotrexate and metoprine uptake and metabolic effectiveness.
Mol Pharmacol. 1979 Sep;16(2):607-13.
3
4
Impaired responsiveness to folinic acid protection in methotrexate-resistant L5178Y cells.
Eur J Cancer (1965). 1975 Sep;11(9):627-32. doi: 10.1016/0014-2964(75)90097-3.
5
Studies with a 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP)-resistant L1210 leukemia cell line without cross-resistance to methotrexate.对2,4-二氨基-5-(3',4'-二氯苯基)-6-甲基嘧啶（DDMP）耐药且对甲氨蝶呤无交叉耐药性的L1210白血病细胞系进行的研究。
Biochem Pharmacol. 1980 Aug 15;29(16):2241-5. doi: 10.1016/0006-2952(80)90204-x.
6
The intracellular mechanism of action of metoprine (DDMP).
Eur J Cancer (1965). 1980 Dec;16(12):1547-54. doi: 10.1016/0014-2964(80)90027-4.
7
Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
Mol Pharmacol. 1981 Nov;20(3):637-43.
8
New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
Cancer Res. 1979 Sep;39(9):3612-8.
9
Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.
Cancer Res. 1985 Mar;45(3):978-82.
10
An antifolate-induced lesion in newly synthesized DNA.
Adv Enzyme Regul. 1980;19:295-308. doi: 10.1016/0065-2571(81)90021-2.
Zotero 插件